Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
type: MedicalStudy
description: An Open-label, Phase II Study to Explore the Safety and Efficacy of Imatinib With Chemotherapy in Pediatric Patients With Ph+ / BCR-ABL+ Acute Lymphoblastic Leukemia (Ph+ALL)
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE2
start date: 2005-12
end date: 2017-03-03
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00287105
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Rennes University Hospital
study subject: Acute Lymphoblastic Leukemia
study subject: Philadelphia Chromosome
keywords: PHASE2
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Acute Lymphoblastic Leukemia
keywords: Philadelphia Chromosome

AI Analytics
type: Organization